English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [353]
News [2110]
Articles [68]
Editorials [3]
Conferences [71]
elearning [17]
Ageism in oncology - issues addressed at EHA
Ageism in oncology - issues addressed at EHA
Cardiologists discover cancer risks in group of blood pressure medications
Cardiologists discover cancer risks in group of blood pressure medications
EHA 2010: New public health initiative launched to change ageism in cancer care
EHA 2010: New public health initiative launched to change ageism in cancer care
ASCO 2010: Breast cancers spread to the liver may change biology, impacting treatment effectiveness
ASCO 2010: Breast cancers spread to the liver may change biology, impacting treatment effectiveness
ASCO 2010: New chemo agent increases overall survival for metastatic breast cancer
ASCO 2010: New chemo agent increases overall survival for metastatic breast cancer
ASCO 2010: Bevacizumab prolongs progression-free survival for advanced ovarian cancer
ASCO 2010: Bevacizumab prolongs progression-free survival for advanced ovarian cancer
ASCO 2010: Single does radiation therapy could be the new standard in breast cancer
ASCO 2010: Single does radiation therapy could be the new standard in breast cancer
ASCO 2010: Novel targeted agent for children with drug-resistant medulloblastoma
ASCO 2010: Novel targeted agent for children with drug-resistant medulloblastoma
ASCO 2010: Ipilimumab improves long-term survival in previously treated advanced melanoma
ASCO 2010: Ipilimumab improves long-term survival in previously treated advanced melanoma
ASCO 2010: Novel ALK inhibitor shows high response rate in patients with advanced NSCLC with specific ALK gene alteration
ASCO 2010: Novel ALK inhibitor shows high response rate in patients with advanced NSCLC with specific ALK gene...
<1...186187188189190...211>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top